Sofosbuvir fights Hepatitis C, but at $84,000, access sparks a DIY revolution amidst a deadly epidemic.
Sofosbuvir, sold as Sovaldi by Gilead Sciences, is an effective drug used to treat Hepatitis C, a virus responsible for 250,000 deaths annually. While traditional treatments last up to a year with cure rates around 70%, a 12-week course of Sovaldi – taking one pill a day – boasts a 90% cure rate. However, the ...